Any current/future new fundraising through debt or equity?

No explicit mention of any current or planned fundraising through debt or equity in the call. Company has been focusing on prudent capital allocation and early repayment of debt; recently reduced debt with Long-term debt at Rs. 33 crores and short-term borrowings at Rs. 52 crores. Liquid cash and investments stand at Rs. 63 crores, indicating a healthy balance sheet position. Near future CAPEX will be limited to maintenance and payback only, suggesting no immediate large capital expenditure requiring fundraising. On share capital reduction or buyback, management stated decisions will be taken

Any current/future capex/capital investment/strategic investment?

Current CAPEX is restricted mainly to maintenance and payback investments. No immediate plans for major capacity expansions; Phase-2 expansion will be considered only when utilization exceeds 85-90%. The company continues to deploy capital year-on-year in private equity and venture investments, seeking good opportunities. Debt repayments have been prioritized, with a healthy balance sheet maintained. Future capital allocation decisions, including potential strategic investments or buybacks, will be made with shareholders' best interests in mind and at appropriate times. Focus remains on pruden

Future growth expectations in sales/revenue/volumes?

The company expects global insoluble sulphur demand growth of around 3-4% annually. Domestic demand growth is anticipated to be higher, around 8-10%, driven by the Indian market. Plans to expand market footprint both geographically and by targeting global manufacturers. Growth expected to outpace overall global market growth due to opportunities in untapped geographies and manufacturers. Phase-2 capacity expansion will be considered once utilization exceeds 85-90%. Revenue growth observed: FY24 total income was Rs. 401 crores, a 14% year-on-year increase. Volume growth has contributed to recen

Future growth expectations in earnings/operating earnings/profits/EPS?

Company expects growth despite current challenges from global chemical inventory destocking and sluggish demand, especially in Europe. Domestic demand projected growth of 8%-10%, higher than global average of 3%-4%, supporting better growth rates. Margin pressure expected to continue with around 4%-5% reduction per ton basis over next 2-3 years due to overcapacity and dumping. Anti-dumping duties pursued to support margin sustainability. Capacity utilization currently around 70%; expansion will be considered when utilization crosses 85%-90%. Growth expected from increasing penetration in untap

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Carbon and Chemicals Limited. However, it is noted that the company is experiencing volume growth and increased sales in certain quarters. There is mention of market challenges, especially in North America and Europe, which impact order levels and penetration. The company expects growth above the global average due to higher domestic market demand (8-10%). Management highlighted that demand in Europe is stabilized but subdued; North American market penetration is ongoing but slower due

AG Ventures LtdQ4 FY24Chemicals & Petrochemicals

AG Ventures Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹129.2P/E: 5.7Market Cap: ₹128 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 4

Fundraise

Order

N/A

Capex

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

The company expects global insoluble sulphur demand growth of around 3-4% annually.
Domestic demand growth is anticipated to be higher, around 8-10%, driven by the Indian market.
Plans to expand market footprint both geographically and by targeting global manufacturers.
Growth expected to outpace overall global market growth due to opportunities in untapped geographies and manufacturers.
Phase-2 capacity expansion will be considered once utilization exceeds 85-90%.
Revenue growth observed: FY24 total income was Rs. 401 crores, a 14% year-on-year increase.
Volume growth has contributed to recent performance improvements.
Margin pressures expected due to oversupply and dumping, but company plans to sustain business through anti-dumping measures.
Short-term CAPEX focused on maintenance; no major expansions planned until capacity utilization hits thresholds.
Company is well-positioned to ramp up capacity utilization quickly when demand recovers.

Margin guidance

Category 4

Company expects growth despite current challenges from global chemical inventory destocking and sluggish demand, especially in Europe.
Domestic demand projected growth of 8%-10%, higher than global average of 3%-4%, supporting better growth rates.
Margin pressure expected to continue with around 4%-5% reduction per ton basis over next 2-3 years due to overcapacity and dumping.
Anti-dumping duties pursued to support margin sustainability.
Capacity utilization currently around 70%; expansion will be considered when utilization crosses 85%-90%.
Growth expected from increasing penetration in untapped geographies and global manufacturers.
Demerger intended to unlock significant value and enhance capital flexibility.
General engineering segment has positive outlook with new product development.
Overall, company aims for growth exceeding global industry average through focused strategies and improving capacity utilization.

See what AG Ventures Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No explicit mention of any current or planned fundraising through debt or equity in the call.
Company has been focusing on prudent capital allocation and early repayment of debt; recently reduced debt with Long-term debt at Rs. 33 crores and short-term borrowings at Rs. 52 crores.
Liquid cash and investments stand at Rs. 63 crores, indicating a healthy balance sheet position.
Near future CAPEX will be limited to maintenance and payback only, suggesting no immediate large capital expenditure requiring fundraising.
On share capital reduction or buyback, management stated decisions will be taken at an appropriate time best serving investors but gave no definite plans on equity raising.
Overall, no clear plans for new debt or equity fundraising were disclosed during the call.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Carbon and Chemicals Limited.
However, it is noted that the company is experiencing volume growth and increased sales in certain quarters.
There is mention of market challenges, especially in North America and Europe, which impact order levels and penetration.
The company expects growth above the global average due to higher domestic market demand (8-10%).
Management highlighted that demand in Europe is stabilized but subdued; North American market penetration is ongoing but slower due to domestic competition.
The company is focusing on customer approvals and expanding its footprint geographically and among global manufacturers.
They expect capacity utilization improvements and order inflow to boost value for stakeholders when market conditions improve.

See what AG Ventures Ltd management said on order book — free account, 30 seconds.

Capex plans

Current CAPEX is restricted mainly to maintenance and payback investments.
No immediate plans for major capacity expansions; Phase-2 expansion will be considered only when utilization exceeds 85-90%.
The company continues to deploy capital year-on-year in private equity and venture investments, seeking good opportunities.
Debt repayments have been prioritized, with a healthy balance sheet maintained.
Future capital allocation decisions, including potential strategic investments or buybacks, will be made with shareholders' best interests in mind and at appropriate times.
Focus remains on prudent capital allocation and strengthening of the company’s financial position rather than aggressive expansion at present.

Track AG Ventures Ltd — get its next earnings analysis in your feed

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAG Ventures Ltd

Rev 4Mar 4

See where AG Ventures Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Compare AG Ventures Ltd against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

AG Ventures Ltd Q4 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Continue your research

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season